SA

Shubhangi Ashwin Kharat

Active Director Director DIN 10322904
DIN 10322904 First appointment Sep 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubhangi Ashwin Kharat

Data last updated:

Shubhangi Ashwin Kharat is a Director at Innoscience Research Private Limited (since 2023). The company operates in Pharma.

DIN 10322904
Primary Designation Director
Industry Pharma
First Appointment 15 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Innoscience Research Private Limited U72100MH2023PTC410575
Director15 Sep 20232023Active

Board colleagues of Shubhangi Ashwin Kharat

NameDINCompanyDesignation
Sumant Vir Kapoor01796340Innoscience Research Private LimitedDirector

Directorship timeline

Open interactive timeline →
Innoscience Research Private Limited
Premium access

Shareholding and investment profile for Shubhangi Ashwin Kharat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubhangi Ashwin Kharat

Shubhangi Ashwin Kharat currently holds 1 directorship: Innoscience Research Private Limited (Director, since 15 Sep 2023).

Shubhangi Ashwin Kharat was first appointed on 15 Sep 2023 as Director at Innoscience Research Private Limited.

The current boards of Shubhangi Ashwin Kharat's companies include Sumant Vir Kapoor (Innoscience Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available